发明名称 Biological magnetic fluids.
摘要 <p>A biological magnetic fluid includes a magnetic colloidal disperse phase distributed throughout a liquid dispersion medium. The disperse phase may be made up of magnetic particles coated with cross-linked biologically compatible polymers. The biologically compatible polymers may be connected by way of covalent linkages to biologically active macromolecules. This may be accomplished by covalently linking immunoglobulin to the biologically compatible polymers and then attaching antibodies with predefined specificity to the immunoglobulin. These antibodies may target the magnetic particles on desired cells, for a variety of medical applications. The magnetic particles may be made up of magnetite cores with cobalt or cobalt and boron coatings. In addition magnetic particles may be made of cobalt and boron with the boron being in sufficient concentration to enable radiation activation. The magnetic colloid may be formed by incorporating the biologically compatible polymer into the colloid as the colloid is being formed by reducing a magnetic metallic salt. The colloid is advantageously produced in a multi-stage process in order to achieve very uniform particle sizes. The magnetic colloid may also be made by forming a biologically incompatible magnetic colloid, and slowly adding the colloid to a vigorous biologically compatible polymer. These biological magnetic fluids are useful, for example, in separating cancerous cells from normal cells in bone marrow transplants.</p>
申请公布号 EP0156537(A2) 申请公布日期 1985.10.02
申请号 EP19850301442 申请日期 1985.03.01
申请人 BOARD OF REGENTS UNIVERSITY OF TEXAS SYSTEM 发明人 POYNTON, CHRISTOPHER H.;READING, CHRISTOPHER L.
分类号 C01G49/00;A61K9/107;A61K9/50;A61K33/00;A61K35/14;A61K35/28;A61K38/00;A61K38/16;A61K39/00;A61M1/36;B03C1/01;C07K14/76;C07K16/00;C07K17/14;G01N33/543;G01N33/545;G01N33/553;H01F1/12;(IPC1-7):H01F1/37;H01F1/28 主分类号 C01G49/00
代理机构 代理人
主权项
地址